Additionally, Wu et al. (2014) reported that fatty acid synthetase (FASN), a key cytosolic enzyme regulating de novo lipogenesis, in mammalian cells, is overexpressed in most cancers and contributes to cell survival and drug resistance [51]. The gene discussed is FASN; the disease is cancer.